AAAAAA
Results: 1-25/53
Authors:
Kitchen, PRB
Smith, HJ
Henderson, MA
Goldhirsch, A
Castiglione-Gertsch, M
Coates, AS
Gusterson, B
Brown, RW
Gelber, RD
Collins, JP
Citation: Prb. Kitchen et al., Tubular carcinoma of the breast: Prognosis and response to adjuvant systemic therapy, AUST NZ J S, 71(1), 2001, pp. 27-31
Authors:
Colleoni, M
Gelber, RD
Gelber, S
Castiglione-Gertsch, M
Coates, AS
Goldhirsch, A
Citation: M. Colleoni et al., How to improve timing and duration of adjuvant chemotherapy, BREAST, 10, 2001, pp. 101-105
Authors:
Thurlimann, B
Price, KN
Castiglione, M
Coates, AS
Goldhirsch, A
Gelber, RD
Forbes, J
Holmberg, S
Veronesi, A
Bernhard, J
Zahrieh, D
Citation: B. Thurlimann et al., Randomized controlled trial of ovarian function suppression plus tamoxifenversus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11-93, BREAST, 10, 2001, pp. 130-138
Authors:
Bonetti, M
Gelber, RD
Goldhirsch, A
Castiglione-Gertsch, M
Coates, AS
Citation: M. Bonetti et al., Features that predict responsiveness to chemotherapy and endocrine therapies, BREAST, 10, 2001, pp. 147-157
Authors:
Coates, AS
Hurny, C
Peterson, HF
Bernhard, J
Castiglione-Gertsch, M
Gelber, RD
Goldhirsch, A
Citation: As. Coates et al., Quality of life scores predict outcome in metastatic but not in early breast cancer, BREAST, 10, 2001, pp. 164-170
Authors:
Curigliano, G
Ferretti, G
Colleoni, M
Marrocco, E
Peruzzotti, G
De Cicco, C
Paganelli, G
Goldhirsch, A
Citation: G. Curigliano et al., Bone scan had no role in the staging of 765 consecutive operable T1-2N0-1 breast cancer patients without skeletal symptoms, ANN ONCOL, 12(5), 2001, pp. 724-725
Authors:
Crivellari, D
Pagani, O
Veronesi, A
Lombardi, D
Nole, F
Thurlimann, B
Hess, D
Borner, M
Bauer, J
Martinelli, G
Graffeo, R
Sessa, C
Goldhirsch, A
Citation: D. Crivellari et al., High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel, ANN ONCOL, 12(3), 2001, pp. 353-356
Authors:
Nole, F
Munzone, E
Mandala, M
Catania, C
Orlando, L
Zampino, MG
Minchella, I
Colleoni, M
Peruzzotti, G
Marrocco, E
Goldhirsch, A
Citation: F. Nole et al., Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: A phase II study, ANN ONCOL, 12(1), 2001, pp. 95-100
Authors:
Gelber, S
Coates, AS
Goldhirsch, A
Castiglione-Gertsch, M
Marini, G
Lindtner, J
Edelmann, DZ
Gudgeon, A
Harvey, V
Gelber, RD
Citation: S. Gelber et al., Effect of pregnancy on overall survival after the diagnosis of early-stagebreast cancer, J CL ONCOL, 19(6), 2001, pp. 1671-1675
Authors:
Colleoni, M
Gelber, S
Coates, AS
Castiglione-Gertsch, M
Gelber, RD
Price, K
Rudenstam, CM
Lindtner, J
Collins, J
Thurlimann, B
Holmberg, SB
Cortes-Funes, H
Simoncini, E
Murray, E
Fey, M
Goldhirsch, A
Citation: M. Colleoni et al., Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer, J CL ONCOL, 19(21), 2001, pp. 4141-4149
Authors:
Goldhirsch, A
Glick, JH
Gelber, RD
Coates, AS
Senn, HJ
Citation: A. Goldhirsch et al., Meeting highlights: International consensus panel on the treatment of primary breast cancer, J CL ONCOL, 19(18), 2001, pp. 3817-3827
Authors:
Colleoni, M
Goldhirsch, A
Coates, A
Gelber, R
Castiglione-Gertsch, M
Citation: M. Colleoni et al., Bone metastases in breast cancer: How to prevent? In reply, J CL ONCOL, 19(10), 2001, pp. 2764-2765
Authors:
Curigliano, G
Ferretti, G
Flamini, G
Goldhirsch, A
de Braud, F
Calabro, MG
Mandaly, M
Nole, F
De Pas, T
D'Addessi, A
Cittadini, A
Citation: G. Curigliano et al., Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradientgel electrophoresis urinalysis, ANTICANC R, 21(4B), 2001, pp. 3015-3020
Authors:
De Pas, T
de Braud, F
Mandala, M
Curigliano, G
Catania, C
Ferretti, G
Sozzi, P
Solli, P
Goldhirsch, A
Citation: T. De Pas et al., Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine, LUNG CANC, 31(2-3), 2001, pp. 267-270
Authors:
Cole, BF
Gelber, RD
Gelber, S
Coates, AS
Goldhirsch, A
Citation: Bf. Cole et al., Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis, LANCET, 358(9278), 2001, pp. 277-286
Authors:
Biffi, R
De Braud, F
Orsi, F
Pozzi, S
Arnaldi, P
Goldhirsch, A
Rotmensz, N
Robertson, C
Bellomi, M
Andreoni, B
Citation: R. Biffi et al., A randomized, prospective trial of central venous ports connected to standard open-ended or groshong catheters in adult oncology patients, CANCER, 92(5), 2001, pp. 1204-1212
Authors:
Mancuso, P
Burlini, A
Pruneri, G
Goldhirsch, A
Martinelli, G
Bertolini, F
Citation: P. Mancuso et al., Resting and activated endothelial cells are increased in the peripheral blood of cancer patients, BLOOD, 97(11), 2001, pp. 3658-3661
Authors:
Munzone, E
Nole, F
Orlando, L
Mandala, M
Biffi, R
Ciano, C
Villa, G
Civelli, M
Goldhirsch, A
Citation: E. Munzone et al., Unexpected right phrenic nerve injury during 5-fluorouracil continuous infusion plus cisplatin and vinorelbine in breast cancer patients, J NAT CANC, 92(9), 2000, pp. 755-755
Authors:
Ferretti, G
Curigliano, G
Pastorino, U
Cittadini, A
Flamini, G
Calabro, MG
De Pas, T
Orlando, L
Mandala, M
Colleoni, M
Spaggiari, L
Granone, PL
Pagliari, G
de Braud, F
Fazio, N
Goldhirsch, A
Citation: G. Ferretti et al., Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer, CLIN CANC R, 6(6), 2000, pp. 2393-2400
Authors:
Colleoni, M
Orlando, L
Nole, F
Goldhirsch, A
Citation: M. Colleoni et al., Introducing taxanes in the adjuvant treatment of breast cancer: expectations and reality, BREAST, 9(3), 2000, pp. 134-138
Authors:
Castiglione-Gertsch, M
Gelber, RD
O'Neill, A
Coates, AS
Goldhirsch, A
Citation: M. Castiglione-gertsch et al., Systemic adjuvant treatment for premenopausal node-negative breast cancer, EUR J CANC, 36(4), 2000, pp. 549-550
Authors:
Piccart, M
Goldhirsch, A
Straehle, C
Citation: M. Piccart et al., The Breast International Group: a new spirit of collaboration in breast cancer research for the new millennium, EUR J CANC, 36(14), 2000, pp. 1733-1736
Authors:
Pagani, O
Sessa, C
Nole, F
Crivellari, D
Lombardi, D
Thurlimann, B
Hess, D
Borner, M
Bauer, J
Martinelli, G
Graffeo, R
Zucchetti, M
D'Incalci, M
Goldhirsch, A
Citation: O. Pagani et al., Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I-II study, ANN ONCOL, 11(8), 2000, pp. 985-991
Authors:
Colleoni, M
Minchella, I
Mazzarol, G
Nole, F
Peruzzotti, G
Rocca, A
Viale, G
Orlando, L
Ferretti, G
Curigliano, G
Veronesi, P
Intra, M
Goldhirsch, A
Citation: M. Colleoni et al., Response to primary chemotherapy in breast cancer patients with tumors notexpressing estrogen and progesterone receptors, ANN ONCOL, 11(8), 2000, pp. 1057-1059
Authors:
De Pas, T
de Braud, F
Danesi, R
Sessa, C
Catania, C
Curigliano, G
Fogli, S
del Tacca, M
Zampino, G
Sbanotto, A
Rocca, A
Cinieri, S
Marrocco, E
Milani, A
Goldhirsch, A
Citation: T. De Pas et al., Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naive patients with advanced non-small-cell lung cancer, ANN ONCOL, 11(7), 2000, pp. 821-827